Comparing Cibinqo vs Olumiant
| Cibinqo (abrocitinib) | Olumiant (baricitinib) |
|
|---|
| Cibinqo (abrocitinib) | Olumiant (baricitinib) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Atopic Dermatitis. Cibinqo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Alopecia, Rheumatoid Arthritis, COVID-19. Olumiant may also be used for purposes not listed in this medication guide. |
||||||||||||||||
| More about Cibinqo (abrocitinib) | More about Olumiant (baricitinib) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Cibinqo has an average rating of 8.6 out of 10 from a total of 5 ratings on Drugs.com. 80% of reviewers reported a positive effect, while 0% reported a negative effect. |
Olumiant has an average rating of 8.2 out of 10 from a total of 15 ratings on Drugs.com. 87% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Cibinqo side effects |
View all Olumiant side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Cibinqo prices |
View all Olumiant prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
5 hours |
12.5 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 574 drugs are known to interact with Cibinqo:
|
A total of 508 drugs are known to interact with Olumiant:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
January 14, 2022 |
May 31, 2018 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.